Clinical Trials Browser

Completed × INDUSTRY × Tuberous Sclerosis Complex-associated Refractory Seizures × Clear all

NCT01713946 2018-11-07

EXIST-3

Phase 3 Completed

366 enrolled 38 charts 1 FDA

Tuberous Sclerosis Complex-associated Refractory Seizures